Share This Author
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial
- S. Cummings, S. Eckert, V. Jordan
- Medicine
- 1 February 2000
TLDR
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
- O. Abe, R. Abe, L. Martino
- MedicineThe Lancet
- 14 May 2005
Establishment and characterization of three new continuous cell lines derived from human breast carcinomas.
- L. Engel, N. Young, T. S. Tralka, M. Lippman, S. O’Brien, M. Joyce
- BiologyCancer research
- 1 October 1978
TLDR
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines
- E. Thompson, S. Paik, R. Dickson
- Biology, MedicineJournal of cellular physiology
- 1 March 1992
TLDR
Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer.
- J. Jacobson, D. Danforth, P. Okunieff
- MedicineThe New England journal of medicine
- 6 April 1995
TLDR
Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial
TLDR
Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays.
- J. Rae, M. Johnson, M. Lippman, D. Flockhart
- Biology, MedicineThe Journal of pharmacology and experimental…
- 1 December 2001
TLDR
Tamoxifen for early breast cancer: an overview of the randomised trials
- O. Abe, R. Abe, H. Caffier
- MedicineThe Lancet
- 16 May 1998
MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.
- N. Brünner, T. Frandsen, R. Clarke
- Biology, MedicineCancer research
- 15 July 1993
TLDR
...
...